However, Pirh2 knockdown enabled the transition of MM cells from G1 phase to S and G2 phases in the presence of bortezomib (Fig. 4D) and weakened the inhibition of cell proliferation by bortezomib (Fig. 4E). This evidence concerns the gene RCHY1 and Miyoshi myopathy.